Sarepta Therapeutics (SRPT) Appoints Edward Kaye as Permanent CEO; Updates on Exec Team
Tweet Send to a Friend
Sarepta Therapeutics (Nasdaq: SRPT) disclosed the following in a U.S. SEC filing on Wednesday morning:Item 5.02 Departure of Directors or ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
